GlaxoSmithKline | DEBITO



Debt Cambiamento Data
AbbVie USD 69.89B 2.74B 2025-03
Alcon AG USD 5.19B 551M 2025-03
Almirall EUR 341.5M 67.31M 2025-03
Amgen USD 56.2B 1.18B 2025-06
argenx SE 43.15M 4.1M 2025-06
AstraZeneca USD 32.84B 1.19B 2025-06
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.59B 296.8M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Eli Lilly USD 39.9B 1.39B 2025-06
Fresenius EUR 12.85B 778M 2025-06
Fresenius Medical Care EUR 11.02B 203.55M 2025-06
Galapagos EUR 10.86M 864K 2025-03
Genmab DKK 148M 5M 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
GRIFOLS EUR 8.82B 1.23B 2025-06
Hikma Pharmaceutical USD 1.31B 30M 2024-12
Lonza CHF 4.71B 915M 2024-12
Merck EUR 9.4B 704M 2025-06
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.27B 12M 2025-03
Novo Nordisk 118.72B 61.75B 2025-03
Orion EUR 321.2M 6M 2025-03
Pfizer USD 60.93B 1.18B 2025-06
Philips EUR 8.43B 857M 2025-06
Recordati EUR 2.47B 112.82M 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 22.28B 1.24B 2025-06
Smith & Nephew USD 3.32B 334M 2024-12
UCB EUR 3.03B 12M 2024-12


GlaxoSmithKline DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.